The primary goal of Dr. Ferrell's research is to improve our understanding of hematologic malignancies in general, and acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) in particular, by using single cell approaches for therapeutic discovery. A focus of his research has been to use clinical samples collected at different time points during therapy to understand contributors to disease relapse and therapy resistance. He uses a multimodal approach to understand how single-cell and bulk leukemia signaling, epigenetics and gene expression affect these outcomes. Other projects in the lab include investigation novel natural products in AML, dissection of innate immune signaling in MDS, and characterization of cellular changes in AML from diagnosis to relapse.

Get the latest thought leadership on AML delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.

Thanks to our HealthTree Community for AML Sponsors:

Bristol Myers Squibb
Jazz Pharmaceuticals
AbbVie
Genentech
Amgen

Follow Us

facebook instagram twitter youtube

 

Terms of Use and Privacy Policy     Newsroom     About    Donations    Find an AML Specialist     Newsletter     Learn     Connect

 

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / HealthTree for AML is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

https://www.guidestar.org/profile/45-5354811